Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07768891 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT07768891 · ClinicalTrials.gov record · last posted 2026-08-17

Beclometasone Dipropionate and Formoterol Inhalation Aerosol for Asthma

StatusRecruiting
PhasePhase 3
Started2026-06-08
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
A multicenter, randomized, double-blind, active-controlled, parallel-group Phase III clinical study comparing the efficacy and safety of Beclometasone Dipropionate and Formoterol Inhalation Aerosol versus FOSTER® in patients with asthma. The purpose of this study is to compare the efficacy and safety of the Beclomethasone Dipropionate and Formoterol Fumarate inhalation aerosol (manufactured by Lunan Better Pharmaceutical Co., Ltd.) with FOSTER® in the treatment of patients with asthma.
Trial Details
NCT Number NCT07768891
Lead Sponsor Lunan Better Pharmaceutical Co., LTD.
Conditions Asthma (Diagnosis)
Enrollment 416 participants
Start Date 2026-06-08
Primary Completion 2028-06 (estimated)
Study Completion 2028-06 (estimated)
Updated on ClinicalTrials.gov 2026-08-17